Research Article
Pre- and Postsynaptic Dopamine SPECT in Idiopathic Parkinsonian Diseases: A Follow-Up Study
Table 6
DAT and IBZM SPECT uptake in HC, PD, MSA, and PSP by region and SPECT timepoint.
(a) |
| Baseline | |
HC DAT IBZM |
PD DAT IBZM |
MSA DAT IBZM |
PSP DAT IBZM | Mann-Whitney U test | | Mean | 95% CI | Mean | 95% CI | PD versus HC | Mean | 95% CI | MSA versus HC | Mean | 95% CI | PSP versus HC | PD versus MSA | PD versus PSP | MSA versus PSP | | | | | | P
*
| | | P
*
| | | P
*
| P | P | P |
| Caudate DAT | 4.47 | 4.14–4.80 | 3.18 | 2.94–3.42 | <0.001 | 3.19 | 2.43–3.95 | <0.001 | 2.83 | 2.50–3.15 | <0.001 | ns | ns | (0.075) | Putamen DAT | 4.09 | 3.83–4.36 | 2.47 | 2.32–2.63 | <0.001 | 2.74 | 2.16–3.31 | <0.001 | 2.31 | 2.01–2.61 | <0.001 | ns | ns | (0.075) | Striate DAT | 4.27 | 3.98–4.56 | 2.80 | 2.61–2.98 | <0.001 | 2.95 | 2.31–3.59 | <0.001 | 2.55 | 2.25–2.85 | <0.001 | ns | ns | (0.063) |
| Striate IBZM | 1.82 | 1.74–1.91 | 1.79 | 1.73–1.85 | 1.00 | 1.84 | 1.66–2.03 | 1.00 | 1.79 | 1.70–1.88 | 1.00 | ns | ns | ns |
|
|
(b) |
| Year 1 | |
PD DAT IBZM |
MSA DAT IBZM |
PSP DAT IBZM | Mann-Whitney U test | | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | PD versus MSA | PD versus PSP | MSA versus PSP | | | | | | | | P | P | |
| Caudate DAT | 2.96 | 2.70–3.22 | 3.58 | 3.13–4.02 | 2.78 | 2.43–3.13 | 0.024 | ns | 0.007 | Putamen DAT | 2.28 | 2.13–2.43 | 2.56 | 2.25–2.87 | 2.17 | 1.89–2.46 | (0.060) | ns | 0.025 | Striate DAT | 2.59 | 2.40–2.79 | 3.02 | 2.67–3.38 | 2.45 | 2.15–2.76 | 0.029 | ns | 0.014 |
| Striate IBZM | 1.73 | 1.67–1.78 | 1.88 | 1.71–2.05 | 1.64 | 1.49–1.78 | (0.051) | ns | 0.026 |
|
|
(c) |
| Year 3 | |
HC DAT IBZM |
PD DAT IBZM |
MSA DAT IBZM |
PSP DAT IBZM | Mann-Whitney U test | | Mean | 95% CI | Mean | 95% CI | PD versus HC | Mean | 95% CI | MSA versus HC | Mean | 95% CI | PSP versus HC | PD versus MSA | PD versus PSP | MSA versus PSP | | | | | | P
*
| | | P
*
| | | P
*
| P | P | P |
| Caudate DAT | 4.35 | 4.06–4.63 | 2.83 | 2.55–3.12 | <0.001 | 2.70 | 2.28–3.12 | <0.001 | 2.38 | 1.80–2.96 | <0.001 | ns | ns | ns | Putamen DAT | 3.96 | 3.71–4.21 | 2.13 | 1.97–2.30 | <0.001 | 2.03 | 1.80–2.26 | <0.001 | 1.92 | 1.50–2.34 | <0.001 | ns | ns | ns | Striate DAT | 4.14 | 3.88–4.40 | 2.45 | 2.24–2.67 | <0.001 | 2.33 | 2.03–2.63 | <0.001 | 2.12 | 1.64–2.61 | <0.001 | ns | ns | ns |
| Striate IBZM | 1.70 | 1.65–1.75 | 1.66 | 1.61–1.72 | 1.0 | 1.92 | 1.71–2.13 | 0.003 | 1.70 | 1.57–1.83 | 1.00 | 0.002 | ns | 0.016 |
|
|
Left and right uptake ratios are averaged.*One way ANOVA, Bonferroni post-hoc test P value. 95% CI: 95% confidence interval.
|